# Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

> **NCT07370922** · PHASE2 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 80 (actual)

## Conditions studied

- Transfusion Dependent Beta Thalassemia

## Interventions

- **DRUG:** Dulaglutide 0.75Mg/0.5Ml Inj Pen
- **DRUG:** control group (insulin)

## Key facts

- **NCT ID:** NCT07370922
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-22
- **Primary completion:** 2025-11-22
- **Final completion:** 2026-01-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07370922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07370922, "Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07370922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*